The Science Beneath the Shell

Article by Dr. Donald Greig

Inflammation sits at the centre of many common medical problems. We see it in painful joints, irritated airways, bowel flare-ups, breast tenderness, pelvic pain, prostatitis and a wide range of chronic inflammatory conditions that can affect quality of life in subtle but persistent ways.

This week I wanted to highlight a natural anti-inflammatory supplement that I have used for almost 3 decades in selected patients as part of a broader wellbeing and prevention programme: Blackmores Lyprinol®, derived from the New Zealand green-lipped mussel.

Lyprinol is not a replacement for conventional medical treatment where that is needed. For some patients, it can be a valuable supportive therapy, particularly where inflammation is part of the picture.

What is Lyprinol?

The story of the green-lipped mussel is also a very human one. Long before it became the subject of modern supplement research, the New Zealand green-lipped mussel, known in Māori as kuku or kūtai, was a traditional and culturally valued food for Māori coastal communities. Later scientific interest in green-lipped mussel extracts was partly sparked by observations that some coastal Māori communities, whose diets included these mussels, appeared to have lower rates of arthritis than inland communities. This does not prove that mussels alone were responsible, but it gives Lyprinol a more personal origin story: a traditional food from the waters of Aotearoa New Zealand that has since been studied for its anti-inflammatory marine lipids.

Lyprinol is a specialised marine oil extract derived from the New Zealand green-lipped mussel, Perna canaliculus. This mussel is native to New Zealand and has attracted medical interest because of its unusual lipid profile, particularly its omega-3 fatty acids and other anti-inflammatory marine lipids.

The active extract in Lyprinol is often referred to as PCSO-524®, a patented, stabilised lipid extract. Blackmores describes Lyprinol as containing 50 mg of specialised non-GMO green-lipped mussel marine oil extract per softgel, used to relieve inflammation, reduce symptoms of mild osteoarthritis, and support general health and wellbeing. 

What makes Lyprinol different from ordinary fish oil is not simply that it contains omega-3 fatty acids. It contains a broader marine lipid fraction from green-lipped mussel, including fatty acids that appear to influence inflammatory pathways.

Why the extraction process matters

Omega-3 fatty acids are delicate. Heat, oxygen and harsh processing can damage or oxidise them and may reduce their biological activity.

One of the reasons Lyprinol has stood out in this area is its patented stabilisation and extraction process, designed to preserve the active marine lipids rather than destroy them during processing. Blackmores describes the product as being extracted using a gentle cold process that preserves its unique marine lipids.

Lyprinol’s own product information also describes PCSO-524® as a patented lipid extract isolated from New Zealand green-lipped mussel, with a process involving stabilisation and freeze-drying before oil extraction. (lyprinolstudies.com)

This matters because, with marine oils, quality is not just about the source. It is also about how the oil is handled, stabilised and protected from oxidation.

How does it work?

Lyprinol appears to work by influencing several inflammatory pathways.

Inflammation is not a single switch. It is a network of chemical signals. Two important pathways are the cyclo-oxygenase pathway, often shortened to COX, and the 5-lipoxygenase pathway, often shortened to 5-LOX. These pathways are involved in producing inflammatory molecules such as prostaglandins and leukotrienes.

Leukotrienes are particularly relevant in conditions such as asthma, allergic inflammation and some forms of chronic inflammatory pain.

The asthma clinical trial published in the European Respiratory Journal noted that experimental studies had shown lipid extract from New Zealand green-lipped mussel to inhibit both the 5-lipoxygenase and cyclo-oxygenase pathways involved in the production of eicosanoids, including leukotrienes and prostaglandins. (pubmed.ncbi.nlm.nih.gov)

In simple terms, Lyprinol may help turn down some of the inflammatory signalling that contributes to pain, swelling, airway irritation and tissue sensitivity.

Lyprinol and asthma

One of the areas where I have found Lyprinol clinically interesting is asthma and airway inflammation.

Asthma is fundamentally an inflammatory condition of the airways. In some patients, inflammation contributes to wheeze, cough, chest tightness and exercise-related bronchospasm.

A randomised, double-blind, placebo-controlled clinical trial published in the European Respiratory Journal studied 46 patients with atopic asthma. Patients received lipid extract from New Zealand green-lipped mussel or placebo for eight weeks. The study found a significant reduction in daytime wheeze, lower exhaled hydrogen peroxide as a marker of airway inflammation, and improved morning peak expiratory flow in the treatment group. No significant side effects were reported. (pubmed.ncbi.nlm.nih.gov)

Another study looked at PCSO-524 in asthmatic subjects with hyperpnoea-induced bronchoconstriction. This was a placebo-controlled, double-blind, randomised crossover trial involving 20 asthmatic subjects. PCSO-524 significantly reduced the fall in post-exercise FEV1, improved asthma symptom scores, reduced rescue medication use, and reduced several inflammatory markers. (pubmed.ncbi.nlm.nih.gov)

This does not mean patients should stop their inhalers. They should not. Asthma medication, especially preventer therapy when prescribed, remains essential. Lyprinol may have a role as an adjunct in selected patients whose symptoms have an inflammatory component.

Lyprinol and arthritis

Joint pain is another common reason patients ask about anti-inflammatory supplements.

Osteoarthritis is often thought of as wear and tear, but inflammation also plays a role in pain, stiffness and reduced mobility.

A multicentre clinical trial of Lyprinol in patients with osteoarthritis of the hip and knee found significant improvement in signs and symptoms after four and eight weeks of treatment. The study reported that 53 percent of patients had significant pain relief at four weeks and 80 percent at eight weeks, with no reported adverse effects during the trial. (pubmed.ncbi.nlm.nih.gov)

Another randomised trial compared PCSO-524 with standard fish oil in osteoarthritis patients. This was not placebo-controlled, but it reported greater improvement in pain symptoms and quality of life in the PCSO-524 group compared with fish oil. (pubmed.ncbi.nlm.nih.gov)

A systematic review of green-lipped mussel supplementation in osteoarthritis has also examined the available clinical trial evidence, including studies using Lyprinol and PCSO-524. As with many supplements, the results are encouraging, but the overall evidence base is still smaller than for conventional licensed medications. (pmc.ncbi.nlm.nih.gov)

In practice, I tend to see Lyprinol as part of a broader joint health plan: weight management, strengthening exercises, mobility work, good footwear, attention to vitamin D where appropriate, and sensible use of medication when needed.

Why it may help beyond joints and lungs

Because Lyprinol acts on inflammatory pathways rather than one single organ, its potential usefulness may extend beyond asthma and arthritis.

In my own clinical practice, I have used it as supportive therapy in selected patients with inflammatory symptoms including:

• mastalgia, or breast pain

• inflammatory bowel disease, as an adjunct alongside specialist care and proven medical pharmaceutical interventions

• prostatitis, particularly when inflammation and pelvic discomfort are prominent

• inflammatory conditions affecting the testicles or epididymal area, after proper assessment to exclude infection, torsion, tumour or other urgent causes

• other recurrent inflammatory pain syndromes where a gentle anti-inflammatory strategy may be useful

The evidence base is stronger in some areas than others. Asthma and osteoarthritis have published clinical trial data, while conditions such as mastalgia, prostatitis and testicular inflammatory pain are more dependent on clinical judgement, biological plausibility and individual patient response.

In my experience, Lyprinol is not an overnight fix. When it helps, it usually needs to be taken consistently for around 6 to 8 weeks before patients can properly judge its benefit. This is important, because occasional or irregular use is unlikely to maintain the level of support needed to influence inflammatory pathways. If it is stopped too early, or taken only now and again, any potential benefit may fall away.

A supplement may be very useful in practice even where formal trial data are limited. Over almost three decades of clinical observation, assessment and interpretation, I have found Lyprinol to be valuable in a wider range of inflammatory conditions than those formally studied. The published evidence is strongest in asthma and osteoarthritis, but my clinical experience suggests its usefulness may extend further, especially where inflammation is a recurring part of the patient’s presentation.

How is Lyprinol different from ordinary omega-3?

Many patients ask whether they can simply take fish oil instead.

Fish oil usually contains the omega-3 fatty acids EPA and DHA. These are beneficial and have been widely studied, particularly in cardiovascular and inflammatory health.

Lyprinol is different because it is a green-lipped mussel lipid extract, not standard fish oil. It contains a more complex marine lipid profile and is produced using a stabilised extraction process intended to protect its active components.

A review article on PCSO-524 noted that green-lipped mussel lipid extracts contain a range of unique polyunsaturated fatty acids, including EPA and DHA as well as other fatty acids that may be relevant to inflammation. (pmc.ncbi.nlm.nih.gov)

Another practical difference is tolerability. Some patients find ordinary fish oil unpleasant because it can cause reflux, burping, or a lingering “fish breath” aftertaste. In my experience, Lyprinol does not seem to cause this in the same way, which can make it easier for patients to take consistently over the several weeks needed to judge its benefit.

In practical terms, I see Lyprinol not as just another fish oil, but as a targeted anti-inflammatory marine lipid supplement.

Who might consider it?

Lyprinol may be worth discussing if you have:

• mild osteoarthritis or joint stiffness

• recurrent inflammatory aches and pains

• asthma or exercise-related airway symptoms

• inflammatory breast pain, menstrual  or non-menstrual cycle related

• prostatitis or pelvic inflammatory discomfort

• inflammatory bowel disease, under medical supervision

• a pattern of inflammation where conventional tests have excluded more serious causes

It is particularly appealing for patients who want a natural adjunct, who prefer to minimise long-term use of stronger anti-inflammatory medication, or who have multiple inflammatory symptoms across different systems.

Important cautions

Natural does not mean suitable for everyone.

Because Lyprinol is derived from mussels, it should generally be avoided by anyone with a shellfish allergy unless specifically advised by their doctor.

Patients taking blood-thinning medication, those due to have surgery, pregnant or breastfeeding women, and people with complex medical conditions should seek medical advice before starting any supplement.

It is also important not to use supplements to mask symptoms that need investigation. New breast pain, rectal bleeding, unexplained weight loss, persistent abdominal pain, testicular pain or swelling, urinary symptoms, breathlessness, or worsening asthma should always be properly assessed.

What I like about Lyprinol is that it fits neatly into a modern approach to wellbeing: reduce inflammation, support resilience, and use natural therapies intelligently alongside evidence-based medicine.

It is not a miracle cure. It is not a substitute for asthma inhalers, arthritis management, bowel disease treatment, prostate assessment or proper investigation of pain.

In the right patient, used for the right reason, it can be a very useful supportive therapy.

For patients with inflammatory symptoms, whether in the joints, airways, breast, bowel, prostate or pelvic area, Lyprinol offers an interesting option derived from one of nature’s most unusual marine sources: the New Zealand green-lipped mussel.

Its value lies not only in its omega-3 content, but in the specialised, stabilised marine lipid extract and the way it appears to influence inflammatory pathways.

Sometimes, good medicine is not about choosing between conventional treatment and natural support. It is about knowing how to combine them safely, sensibly and with a clear understanding of what each can offer.

Please note: Blackmores Lyprinol can sometimes be difficult to source, and it is not widely available in Hong Kong. I do keep it available in my clinic for selected patients where it may be appropriate. If you would like to discuss whether Lyprinol could be suitable for you, please feel free to ask at your next appointment or contact the clinic for further advice.

Disclaimer: This article is intended for general information only and should not be taken as personal medical advice. Lyprinol and other supplements may not be suitable for everyone, particularly those with shellfish allergy, those taking blood-thinning medication, pregnant or breastfeeding women, or patients with complex medical conditions. Please consult your doctor before starting any new supplement, especially if you have persistent, worsening or unexplained symptoms. As always, discuss any treatment decisions with your healthcare provider.

Disclaimer: This newsletter is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for any medical concerns.